Select region :

Asia, Australia / New Zealand, Middle East, China

Site search :

Corporate Associate 2-5 years Tokyo -13/01/2010 A top US firm with an established Tokyo practice is looking for a corporate associate with 2 to 5 years' experience . Expertise in private equity or acquisition finance matters is particularly relevan
Legal Counsel (8-12 yrs pqe) Singapore -14/01/2010 Be part of a global legal team with this leading software solutions multinational.
US Securities associate 3-7 years Hong Kong -12/02/2010 A major US firm is looking for a US securities associate with fluent Mandarin and top academics to join its Hong Kong office.

Corporate Associate 2-5 years Tokyo -13/01/2010

A top US firm with an established Tokyo practice is looking for a corporate associate with 2 to 5 years' experience . Expertise in private equity or acquisition finance matters is particularly relevan

Legal Counsel (8-12 yrs pqe) Singapore -14/01/2010

Be part of a global legal team with this leading software solutions multinational.

US Securities associate 3-7 years Hong Kong -12/02/2010

A major US firm is looking for a US securities associate with fluent Mandarin and top academics to join its Hong Kong office.

More jobs

UTI Asset Management - T. Rowe Price JV

- US$138.00 m

Entry date - Thursday, 7 January 2010
Jurisdiction - India
Practice - M&A
TRP to acquire a 26%stake in UTI Asset Management Co. its UTI Trustee Company

Back

Firm - Amarchand & Mangaldas Client - UTI Asset Management Company Lead Lawyers - SH Bhojani Role - Indian counsel	Firm - Dave Girish and Associates Client - Joint sponsors Lead Lawyers - Role - Indian counsel	Firm - Freshfields Client - TRP Lead Lawyers - Role - Int Counsel
Firm - Platinum Partners Client - TRP Lead Lawyers - Role - Indian counsel

Deal summary

Joint Venture between UTI Asset Management Company and T. Rowe Price - investment in mutual fund business of UTI, through acquisition of shares

TRP to acquire a 26%stake in UTI Asset Management Co. its UTI Trustee Company

Closing pending regulatory approvals as of Nov 09

Did you work on this deal? Let us know and we'll add your details. Email us here.